The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance
Permanent link
https://hdl.handle.net/10037/17476Date
2019-08-21Type
Journal articleTidsskriftartikkel
Peer reviewed
Author
Vandenbroucke-Grauls, Christina MJE; Kahlmeter, Gunnar; Kluytmans, Jan; Kluytmans-Van Den Bergh, Marjolein; Monnet, Dominique L; Simonsen, Gunnar Skov; Skov, Robert L; Wolff Sonksen, Ute; Voss, AndreasAbstract
Summary box
- The Drug Resistance Index (DRI) is proposed as measure of antibiotic effectiveness in a given country, by combining, in a single metric the use of various antibiotic groups and the resistance proportions of several pathogens.
- The DRI is a complicated measure that gives results that cannot be understood by common knowledge and logic.
- The DRI conveys a wrong message. A low DRI is meant to represent good antibiotic efficacy, but a low DRI may be the result of unnecessary, excessive use of too broad-spectrum antibiotics.
- Restrictive use of antibiotics is one of the cornerstones in the fight against antimicrobial resistance, therefore the DRI, whose interpretation may promote the opposite, should not be used.
Publisher
BMJ Publishing GroupCitation
Vandenbroucke-Grauls, Kahlmeter G, Kluytmans J, Kluytmans-Van Den Bergh, Monnet DL, Simonsen GS, Skov RL, Wolff Sonksen U, Voss A. The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance. BMJ Global Health. 2019;4(4)Metadata
Show full item recordCollections
Copyright 2019 The Author(s)